| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract Author Index
|
|
|
2015
|
15 |
S2 |
p. A7-A12
nvt p.
|
artikel
|
| 2 |
Abstract Subject Index
|
|
|
2015
|
15 |
S2 |
p. A13-A15
nvt p.
|
artikel
|
| 3 |
A characterization of cytotoxic CD4+ T lymphocytes in Chronic Lymphocytic Leukemia (CLL) and the identification of their presence in the tumor microenvironment
|
Marzolini, Maria AV.
|
|
2015
|
15 |
S2 |
p. S29-
1 p.
|
artikel
|
| 4 |
Achievement of remission but no type of induction regimen is associated with improved outcomes in double hit lymphomas
|
Melody, Megan
|
|
2015
|
15 |
S2 |
p. S70-S71
2 p.
|
artikel
|
| 5 |
Acute Myeloid Leukemia (AML) Cells Functionally Alter Bone Marrow Microenvironment (BME) to Gain Growth Advantage
|
Battula, V.L.
|
|
2015
|
15 |
S2 |
p. S15-S16
2 p.
|
artikel
|
| 6 |
Adherence to monitoring tests in CML patients in Lebanon
|
Massoud, M.
|
|
2015
|
15 |
S2 |
p. S37-
1 p.
|
artikel
|
| 7 |
Adherence To The Ibrutinib 420 mg Dose Administered To Patients With Previously Treated CLL
|
Burger, Jan A.
|
|
2015
|
15 |
S2 |
p. S24-
1 p.
|
artikel
|
| 8 |
A genomic approach to estimating the heritability of Hodgkin lymphoma
|
Sud, Amit
|
|
2015
|
15 |
S2 |
p. S39-S40
2 p.
|
artikel
|
| 9 |
Allogeneic Hematopoietic Cell Transplantation for AML: is it Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
|
Araki, Daisuke
|
|
2015
|
15 |
S2 |
p. S8-
1 p.
|
artikel
|
| 10 |
Allogeneic stem cell transplantation outcomes in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis
|
Dany, Mohammed
|
|
2015
|
15 |
S2 |
p. S7-
1 p.
|
artikel
|
| 11 |
Allogeneic stem cell transplantation outcomes in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis
|
Rashidi, Armin
|
|
2015
|
15 |
S2 |
p. S9-S10
2 p.
|
artikel
|
| 12 |
Altered Defibrotide Treatment Regimen for Veno-occlusive Disease: A Single Center Experience
|
Yehudai, Dana
|
|
2015
|
15 |
S2 |
p. S78-
1 p.
|
artikel
|
| 13 |
Analysis and clinical correlation of infiltrating cytotoxic T cells in Hodgkin Lymphoma tumor samples using flow cytometry
|
Alonso-Alvarez, Sara
|
|
2015
|
15 |
S2 |
p. S39-
1 p.
|
artikel
|
| 14 |
Analysis of survival of CML patients in the last 15 years in Lebanon
|
Massoud, M.
|
|
2015
|
15 |
S2 |
p. S36-S37
2 p.
|
artikel
|
| 15 |
Anti-leukemia efficacy and mechanisms of action of SL-101, a novel anti-CD123 antibody-conjugate in acute myeloid leukemia
|
Han, Lina
|
|
2015
|
15 |
S2 |
p. S14-
1 p.
|
artikel
|
| 16 |
Antitumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
|
Fernández-Rodríguez, Concepción
|
|
2015
|
15 |
S2 |
p. S61-S62
2 p.
|
artikel
|
| 17 |
A Phase 2 Study to Evaluate Overall Response Rates in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine with or without Deferasirox
|
Duong, Vu H.
|
|
2015
|
15 |
S2 |
p. S48-
1 p.
|
artikel
|
| 18 |
A Single Institution Experience with EPOCH in Peripheral T-cell Lymphomas (PTCL)
|
Rotta, Marcello
|
|
2015
|
15 |
S2 |
p. S68-
1 p.
|
artikel
|
| 19 |
At-home Management of Adult Patients Following Consolidation Chemotherapy for Acute Myeloid Leukemia
|
Gaya, Anna
|
|
2015
|
15 |
S2 |
p. S12-S13
2 p.
|
artikel
|
| 20 |
Autologous Hemapoietic Stem Cell Mobilisation and Harvest in Non Hodgkin’s Lymphoma: Single Center Experience
|
Mutlu, Cansu Atmaca
|
|
2015
|
15 |
S2 |
p. S67-S68
2 p.
|
artikel
|
| 21 |
Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience
|
Alameddine, Raafat S.
|
|
2015
|
15 |
S2 |
p. S41-
1 p.
|
artikel
|
| 22 |
Bilateral Cranial Nerve Palsy as a Harbinger of Acute Lymphoblastic Leukemia
|
Sen, Shiraj
|
|
2015
|
15 |
S2 |
p. S2-
1 p.
|
artikel
|
| 23 |
BL-8040, A novel CXCR4 inhibitor, affects AML blasts survival and induces their terminal differentiation
|
Abraham, Michal
|
|
2015
|
15 |
S2 |
p. S12-
1 p.
|
artikel
|
| 24 |
Bone marrow iron store (BMIS) as a predictive marker for survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
|
Sivgin, Serdar
|
|
2015
|
15 |
S2 |
p. S77-S78
2 p.
|
artikel
|
| 25 |
Bone marrow necrosis, an unusual initial presentation of sickle cell anemia
|
El Hachem, Georges
|
|
2015
|
15 |
S2 |
p. S77-
1 p.
|
artikel
|
| 26 |
CD2 positive acute promyelocytic leukemia is high risk of relapse and associated with expression of CD34 and FLT3-ITD mutation
|
Nagasaka, Isao
|
|
2015
|
15 |
S2 |
p. S13-
1 p.
|
artikel
|
| 27 |
Characteristics and Outcome of 66 Patients with Extramedullary Plasmacytomas (EMPs) Included in a Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
|
Jiménez-Segura, Raquel
|
|
2015
|
15 |
S2 |
p. S52-
1 p.
|
artikel
|
| 28 |
Characteristics, Treatment and Outcomes of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A single institution experience
|
Grussie, Erwin
|
|
2015
|
15 |
S2 |
p. S74-S75
2 p.
|
artikel
|
| 29 |
Clinical and prognostic significance of 3q26 rearrangements and other chromosome 3 abnormalities in chronic myelogenous leukemia in era of tyrosine kinase inhibitors
|
Wang, Wei
|
|
2015
|
15 |
S2 |
p. S32-S33
2 p.
|
artikel
|
| 30 |
Clinical features and treatment outcomes of patients with Necrobiotic Xanthogranuloma (NXG) associated with monoclonal gammopathies (MG)
|
Higgins, Larissa
|
|
2015
|
15 |
S2 |
p. S53-
1 p.
|
artikel
|
| 31 |
Combined Targeting of Bcl-2 and Bcr-Abl Tyrosine Kinase Eradicates Chronic Myeloid Leukemia Stem/Progenitor Cells
|
Carter, Bing Z.
|
|
2015
|
15 |
S2 |
p. S34-
1 p.
|
artikel
|
| 32 |
Comparison of Autologous Hematooetic Stem Cell Mobilization And Harvest Data in HL and NHL Patients
|
Özkan, Melda Cömert
|
|
2015
|
15 |
S2 |
p. S72-
1 p.
|
artikel
|
| 33 |
Consolidation with bortezomib/lenalidomide/dexamethasone post autologous hematopoietic cell transplantation in patients with multiple myeloma: a single-center experience
|
Dalle, Imane Abou
|
|
2015
|
15 |
S2 |
p. S53-S54
2 p.
|
artikel
|
| 34 |
Correlation between peripheral blood and bone marrow samples for detection of PML-RARA fusion transcripts by quantitative PCR in patients with acute promyelocytic leukemia
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S11-S12
2 p.
|
artikel
|
| 35 |
CXCR4 Chemokine Receptor as a therapeutic target in B-Cell Acute Lymphoblastic Leukemia (B-ALL)
|
Randhawa, Shubhchintan
|
|
2015
|
15 |
S2 |
p. S1-S2
2 p.
|
artikel
|
| 36 |
Cytogenetics of Adult Hispanic ALL Patients at Los Angeles County Hospital and Keck Hospital
|
Ghaznavi, Zunera
|
|
2015
|
15 |
S2 |
p. S3-
1 p.
|
artikel
|
| 37 |
Development of a TGFβ-resistant Multi-tumor-associated T Cell Therapeutic for Patients with Acute Myeloid Leukemia
|
McLaughlin, Lauren
|
|
2015
|
15 |
S2 |
p. S78-
1 p.
|
artikel
|
| 38 |
DH DLBCL with Myc/bcl-6 rearrangement and rare cutaneous presentation- a case report
|
Khelfa, Yousef
|
|
2015
|
15 |
S2 |
p. S63-S64
2 p.
|
artikel
|
| 39 |
Diagnostic Role of Lumbar Puncture (LP) for the diagnosis of Central Nervous System (CNS) Involvement by Chronic Lymphocytic Leukemia(CLL)/Richter Syndrome (RS)
|
Strati, Paolo
|
|
2015
|
15 |
S2 |
p. S25-S26
2 p.
|
artikel
|
| 40 |
Diagnostic Significance of Screening for BCR-ABL1 by PCR in Patients with Neutrophilia. The William Beaumont Hospital experience
|
Ogunleye, Foluso
|
|
2015
|
15 |
S2 |
p. S33-
1 p.
|
artikel
|
| 41 |
Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes (MDS)
|
Zeidan, Amer M.
|
|
2015
|
15 |
S2 |
p. S44-S45
2 p.
|
artikel
|
| 42 |
Durable Responses Including Complete Responses in CLL Following Long Term Treatment With Single-agent Ibrutinib 420 mg
|
O'Brien, Susan
|
|
2015
|
15 |
S2 |
p. S23-
1 p.
|
artikel
|
| 43 |
Early Bcr-Abl reduction is predictive of better Event Free Survival in Chronic Myeloid Leukemia newly diagnosed patients treated with any TKIs
|
Fava, Carmen
|
|
2015
|
15 |
S2 |
p. S33-
1 p.
|
artikel
|
| 44 |
Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) in Adults: A High-Risk Subtype
|
Jain, Nitin
|
|
2015
|
15 |
S2 |
p. S7-
1 p.
|
artikel
|
| 45 |
Editorial Board/Masthead
|
|
|
2015
|
15 |
S2 |
p. A2-
1 p.
|
artikel
|
| 46 |
Elevated plasma Epstein-Barr virus DNA at diagnosis predicts a poor prognosis in peripheral T-cell lymphomas
|
Haverkos, Bradley M.
|
|
2015
|
15 |
S2 |
p. S67-
1 p.
|
artikel
|
| 47 |
Eltrombopag use in Chronic Myleomonocytic Leukemia (CMML) Patients: A Cautionary Tale
|
Ramadan, Hanadi
|
|
2015
|
15 |
S2 |
p. S48-S49
2 p.
|
artikel
|
| 48 |
Evaluation of Febrile Neutropenic Episodes in Autologous Hematopoietic Stem Cell Transplantations for Hodgkin Lymphoma
|
Özkan, Melda Cömert
|
|
2015
|
15 |
S2 |
p. S40-S41
2 p.
|
artikel
|
| 49 |
Evaluation of Febrile Neutropenic Episodes in Autologous Hematopoietic Stem Cell Transplantations for NHL
|
Mutlu, Cansu Atmaca
|
|
2015
|
15 |
S2 |
p. S71-S72
2 p.
|
artikel
|
| 50 |
Expression of differential protein phosphatase 2A subunit isoforms correlates with survival in acute myeloid leukemia
|
Benton, Christopher B.
|
|
2015
|
15 |
S2 |
p. S22-
1 p.
|
artikel
|
| 51 |
Expression Of Phosphodiesterase 4 (PDE4) In Myelodysplastic Syndromes (MDS) And Its Impact On Outcome: Result Of A Transcriptome Profiling Using RNA Sequencing From 43 Patients With MDS And Chronic Myelomonocytic Leukemia
|
Chamseddine, Ali N.
|
|
2015
|
15 |
S2 |
p. S45-S46
2 p.
|
artikel
|
| 52 |
First-in-class Anti-tumor Agent ONC201 Induces Apoptosis in Hematological Malignancies with Wild Type and Mutant p53
|
Ishizawa, Jo
|
|
2015
|
15 |
S2 |
p. S73-
1 p.
|
artikel
|
| 53 |
Flow cytometric immunophenotypic study of monocytes in myeloid neoplasms and reactive conditions
|
Cui, Wei
|
|
2015
|
15 |
S2 |
p. S9-
1 p.
|
artikel
|
| 54 |
Front-line Treatment with Ofatumumab in Elderly Unfit Patients with CLL
|
Vitale, Candida
|
|
2015
|
15 |
S2 |
p. S26-
1 p.
|
artikel
|
| 55 |
Genetic alterations in Guatemalan acute myeloid leukemia patients
|
Carranza, Claudia
|
|
2015
|
15 |
S2 |
p. S10-
1 p.
|
artikel
|
| 56 |
Genetic characterization of myeloproliferative neoplasms in Guatemala
|
Guerra, Mariela
|
|
2015
|
15 |
S2 |
p. S56-
1 p.
|
artikel
|
| 57 |
Genomic landscape in KIT D816V+ advanced systemic mastocytosis
|
Jawhar, Mohamad
|
|
2015
|
15 |
S2 |
p. S55-S56
2 p.
|
artikel
|
| 58 |
Haploidentical T-cell replete transplantation with post-transplant cyclophosphamide or matched unrelated donor for patients with high-risk hematologic malignancies? A single-center experience
|
El Cheikh, Jean
|
|
2015
|
15 |
S2 |
p. S80-
1 p.
|
artikel
|
| 59 |
Hematologic Oncology Chemotherapy Stewardship Program: A One Year Institutional Experience
|
Steinberg, Amir
|
|
2015
|
15 |
S2 |
p. S76-S77
2 p.
|
artikel
|
| 60 |
Hepatic iron overload (HIO) is strongly correlated with serum ferritin levels and inferior survival in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
|
Sivgin, Serdar
|
|
2015
|
15 |
S2 |
p. S3-S4
2 p.
|
artikel
|
| 61 |
HEXIM1 induction mechanistically contributes to anti-AML activity of BET protein bromodomain antagonist
|
Fiskus, Warren
|
|
2015
|
15 |
S2 |
p. S10-S11
2 p.
|
artikel
|
| 62 |
HHV-8-positive multicentric variant of Castleman disease
|
Egorova, E.K.
|
|
2015
|
15 |
S2 |
p. S68-S69
2 p.
|
artikel
|
| 63 |
Human T-cell Lymphotropic Virus (HTLV-1) Adult T-cell Leukemia Lymphoma (ATLL): Rarely encountered in the United States
|
Roe, Christa
|
|
2015
|
15 |
S2 |
p. S73-S74
2 p.
|
artikel
|
| 64 |
Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update for a Phase II Clinical Trial
|
Wang, Michael (Luhua)
|
|
2015
|
15 |
S2 |
p. S65-
1 p.
|
artikel
|
| 65 |
Identification of a Novel Regulator of AML
|
Gallardo, Miguel
|
|
2015
|
15 |
S2 |
p. S75-S76
2 p.
|
artikel
|
| 66 |
Imanitib Intolerance is associated to Blastic-phase development in Philadelpia chromosome-positive Chronic Myeloid Leukemia (CML Ph+)
|
Ángeles-Velázquez, Jorge Luis
|
|
2015
|
15 |
S2 |
p. S34-
1 p.
|
artikel
|
| 67 |
Immunoparesis Recovery as Predictor Marker of Progression After Autologous Stem Cell Transplantation in Multiple Myeloma
|
González de la Calle, V.
|
|
2015
|
15 |
S2 |
p. S51-
1 p.
|
artikel
|
| 68 |
Immunophenotypic Characterization of Cytogenetic subgroups in Egyptian Pediatric B-Acute Lymphoblastic Leukemia Patients
|
Awad, Shady
|
|
2015
|
15 |
S2 |
p. S1-
1 p.
|
artikel
|
| 69 |
Immunosuppressive Therapy: Exploring An Underutilized Treatment Option For MDS
|
Haider, M.
|
|
2015
|
15 |
S2 |
p. S49-
1 p.
|
artikel
|
| 70 |
Impact of Molecular Parameters on Treatment outcomes in Large Granular Lymphocyte Leukemia (LGL)
|
Sanikommu, Srinivasa Reddy
|
|
2015
|
15 |
S2 |
p. S29-
1 p.
|
artikel
|
| 71 |
Impact of Mutation Variant Allele Frequency on Phenotype, Outcomes, and Patient Management in Myelodysplastic Syndromes
|
Sallman, David
|
|
2015
|
15 |
S2 |
p. S43-S44
2 p.
|
artikel
|
| 72 |
Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in era of tyrosine kinase inhibitors
|
Wang, Wei
|
|
2015
|
15 |
S2 |
p. S31-S32
2 p.
|
artikel
|
| 73 |
Incidence of Vitamin D Deficiency in Multiple Myeloma Patients and The Relationship Between Chemotherapies, Autologous Stem Cell Transplantation, Bone Density and Fractures
|
Yokus, Osman
|
|
2015
|
15 |
S2 |
p. S50-
1 p.
|
artikel
|
| 74 |
Incidence trend of the leukemia reported cases in the kingdom of Saudi Arabia, observational descriptive statistic from Saudi Cancer Registry
|
Albakr, Rashed B.
|
|
2015
|
15 |
S2 |
p. S2-
1 p.
|
artikel
|
| 75 |
Inclusion of RBC-Transfusion Dependency Improves the Prognostic Value of Revised-IPSS (R-IPSS) in MDS Patients
|
Hiwase, Devendra K.
|
|
2015
|
15 |
S2 |
p. S44-
1 p.
|
artikel
|
| 76 |
Inotuzumab ozogamicin in combination with mini-hyper-CVD as salvage therapy for patients with relapsed/refractory acute lymphoblastic leukemia
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S6-
1 p.
|
artikel
|
| 77 |
Inotuzumab ozogamicin (INO) in combination with mini-hyper-CVD as frontline therapy for older patients (≥60 years) with acute lymphoblastic leukemia (ALL)
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S6-
1 p.
|
artikel
|
| 78 |
Interdigitating dendritic cell sarcoma with immunoglobin rearrangement arrose in a chronic lymphocytic leukemia patient
|
Kentaro, Kohno
|
|
2015
|
15 |
S2 |
p. S67-
1 p.
|
artikel
|
| 79 |
IRAK1/4 and BET bromodomain inhibitions converge in NF-κB blockade and offer synergistic antitumoral activity in ABC-DLBCL with MYD88 mutation
|
Dlouhy, I.
|
|
2015
|
15 |
S2 |
p. S64-S65
2 p.
|
artikel
|
| 80 |
Iron Deficiency Anemia Aasking Myeloproliferative Disorder in a 72 year old female
|
Rahman, Abdul
|
|
2015
|
15 |
S2 |
p. S59-S60
2 p.
|
artikel
|
| 81 |
Is Visual Analogue Scala (VAS) Available for Pain Palliation in Multiple Myeloma Patients?
|
Doğu, Mehmet Hilmi
|
|
2015
|
15 |
S2 |
p. S50-
1 p.
|
artikel
|
| 82 |
JAK2V617F and Platelet Functions
|
Cagliyan, Gulsum Akgun
|
|
2015
|
15 |
S2 |
p. S56-S57
2 p.
|
artikel
|
| 83 |
Lineage-negative, CD34-negative, CD45-negative (Lin-CD34-CD45-) leukemia cells from primary adult AML samples have distinct stem cell-like properties
|
Benton, Christopher B.
|
|
2015
|
15 |
S2 |
p. S21-S22
2 p.
|
artikel
|
| 84 |
Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Follow-up of a Phase 1 Trial
|
Kantarjian, Hagop M.
|
|
2015
|
15 |
S2 |
p. S35-
1 p.
|
artikel
|
| 85 |
Low-dose cytarabine and aclarubicin in combination with G-CSF (CAG) regimen for elderly patients with acute myeloid leukemia and myelodysplastic syndrome: A single institution experience
|
Iwasaki, Junko
|
|
2015
|
15 |
S2 |
p. S17-
1 p.
|
artikel
|
| 86 |
Lymphomatoid Granulomatosis: a Single Tertiary Institution Experience
|
Sandoval-Sus, Jose D.
|
|
2015
|
15 |
S2 |
p. S63-
1 p.
|
artikel
|
| 87 |
MDS patients with TP53 mutation respond equally to hypomethylating agents (HMA) but has significantly shorter response duration compared to patients with wild type TP53
|
Takahashi, Koichi
|
|
2015
|
15 |
S2 |
p. S49-
1 p.
|
artikel
|
| 88 |
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Bhella, Sita D.
|
|
2015
|
15 |
S2 |
p. S79-S80
2 p.
|
artikel
|
| 89 |
Molecular charcterization of myeloproliferative neoplasms evolved to acute myeloid leukemia
|
Fernández, C.
|
|
2015
|
15 |
S2 |
p. S16-S17
2 p.
|
artikel
|
| 90 |
Molecular markers and venous thromboembolism (VTE) in acute myelogenous leukemia (AML)
|
Devata, Sumana
|
|
2015
|
15 |
S2 |
p. S14-S15
2 p.
|
artikel
|
| 91 |
Molecular Rationale for Clinical Development of CYC065 in Hematology
|
Zheleva, Daniella
|
|
2015
|
15 |
S2 |
p. S13-S14
2 p.
|
artikel
|
| 92 |
Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
|
Mauro, Michael J.
|
|
2015
|
15 |
S2 |
p. S37-
1 p.
|
artikel
|
| 93 |
Multilevel Risk Factors of Electronically Measured Medication Non-Adherence in CML
|
Leader, Avi
|
|
2015
|
15 |
S2 |
p. S37-S38
2 p.
|
artikel
|
| 94 |
Mutational Model to Predict Response to Hypomethylating Agents (HMAs) in Myelodysplastic Syndromes (MDS)
|
Nazha, Aziz
|
|
2015
|
15 |
S2 |
p. S43-
1 p.
|
artikel
|
| 95 |
Myelodysplastic Syndromes in Adolescent Young Adults – The Moffitt Experience
|
Grabska, Joanna
|
|
2015
|
15 |
S2 |
p. S47-S48
2 p.
|
artikel
|
| 96 |
Myeloproliferative Neoplasms with Calreticulin Mutations Exhibit Distinctive Morphologic Features
|
Loghavi, Sanam
|
|
2015
|
15 |
S2 |
p. S57-
1 p.
|
artikel
|
| 97 |
Next Gen Sequencing and Digital PCR Analysis of Hematological Cancers
|
Samuels, Michael
|
|
2015
|
15 |
S2 |
p. S19-S20
2 p.
|
artikel
|
| 98 |
Ofatumumab in Combination with Hyper-CVAD Regimen as Frontline Treatment for Adults with CD-20 Positive Acute Lymphocytic Leukemia
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S4-S5
2 p.
|
artikel
|
| 99 |
Optimized Voronoi compartment determination using machine-learning to identify prognostic groups of patients based on cellular behavior in treated AML
|
Benton, Christopher B.
|
|
2015
|
15 |
S2 |
p. S22-
1 p.
|
artikel
|
| 100 |
Other cancers in long-term survivor patients with chronic lymphocytic leukemia
|
Falchi, Lorenzo
|
|
2015
|
15 |
S2 |
p. S26-S27
2 p.
|
artikel
|
| 101 |
Outcomes in Myelofibrosis Patients Completing 24 and 36 Weeks of Treatment with PRM-151
|
Verstovsek, Srdan
|
|
2015
|
15 |
S2 |
p. S58-S59
2 p.
|
artikel
|
| 102 |
Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin
|
Rashidi, Armin
|
|
2015
|
15 |
S2 |
p. S69-
1 p.
|
artikel
|
| 103 |
Paraneoplastic pemphigus in a patient with Chronic Lymphocytic Leukemia (CLL)
|
Rios, Adan
|
|
2015
|
15 |
S2 |
p. S27-
1 p.
|
artikel
|
| 104 |
Peg-filgrastim potentiates rituximab in patients with indolent lymphomas: results of a phase II study
|
Torka, Pallawi
|
|
2015
|
15 |
S2 |
p. S72-
1 p.
|
artikel
|
| 105 |
Pharmacogenomics of Bortezomib in Multiple Myeloma Patients Reveals that the Ubiquitin Ligase SCF-Skp2 Promotes Drug Resistance
|
Driscoll, James J.
|
|
2015
|
15 |
S2 |
p. S54-
1 p.
|
artikel
|
| 106 |
Phase 1/2, dose-escalation study of oral NS-018 in patients with primary myelofibrosis (PMF), post-polycythemia vera MF (post-PV MF), or post-essential thrombocythemia MF(post-ET MF)
|
Verstovsek, Srdan
|
|
2015
|
15 |
S2 |
p. S58-
1 p.
|
artikel
|
| 107 |
Phase II Study of Combination of Hyper-CVAD with Ponatinib in Frontline Therapy of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-positive ALL)
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S5-
1 p.
|
artikel
|
| 108 |
Phase II study of hyper-CMAD with liposomal vincristine as frontline therapy for patients with acute lymphoblastic leukemia
|
Sasaki, Koji
|
|
2015
|
15 |
S2 |
p. S5-
1 p.
|
artikel
|
| 109 |
Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed AML or High-Risk MDS
|
Halpern, Anna B.
|
|
2015
|
15 |
S2 |
p. S11-
1 p.
|
artikel
|
| 110 |
δPI3-K inhibition elicits anti-leukemic effects through the induction of Bim-dependent apoptosis
|
Carter, Matthew J.
|
|
2015
|
15 |
S2 |
p. S27-S28
2 p.
|
artikel
|
| 111 |
Ponatinib in Heavily Pretreated Leukemia: 3-Year PACE Trial Results
|
Cortes, Jorge E.
|
|
2015
|
15 |
S2 |
p. S35-S36
2 p.
|
artikel
|
| 112 |
Pre-clinical activity of BET protein antagonist-based combinations against ibrutinib-sensitive or -resistant human Mantle Cell Lymphoma cells
|
Sun, Baohua
|
|
2015
|
15 |
S2 |
p. S64-
1 p.
|
artikel
|
| 113 |
Predictors of complete response to chemoradiotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal Natural Killer /T-cell Lymphoma at Peruvian Cancer Institute
|
Alattar, Mona Lisa
|
|
2015
|
15 |
S2 |
p. S65-S66
2 p.
|
artikel
|
| 114 |
Predictors of Outcome in HIV-associated Primary Effusion Lymphoma
|
Sen, Shiraj
|
|
2015
|
15 |
S2 |
p. S66-S67
2 p.
|
artikel
|
| 115 |
Predictors of Quality of Life for High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
|
Tinsley, Sara M.
|
|
2015
|
15 |
S2 |
p. S80-
1 p.
|
artikel
|
| 116 |
Predictors of Survival of Natural Killer/T-cell Lymphoma (NKTL), nasal type in a Peruvian Population at a Cancer Institute
|
Vásquez, Jule
|
|
2015
|
15 |
S2 |
p. S66-
1 p.
|
artikel
|
| 117 |
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic experience
|
Kourelis, Taxiarchis V.
|
|
2015
|
15 |
S2 |
p. S51-
1 p.
|
artikel
|
| 118 |
Prevalence and Economic Burden of Chronic Lymphocytic Leukemia (CLL) in the Era of Oral Targeted Therapies
|
Jain, Nitin
|
|
2015
|
15 |
S2 |
p. S30-
1 p.
|
artikel
|
| 119 |
Primary cutaneous B-cell lymphoma: management and patterns of recurrence at the Multimodality Cutaneous Lymphoma Clinic of the Ohio State University
|
Hastings, Justin
|
|
2015
|
15 |
S2 |
p. S62-
1 p.
|
artikel
|
| 120 |
Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms to Treatment
|
Conchon, Monika
|
|
2015
|
15 |
S2 |
p. S57-S58
2 p.
|
artikel
|
| 121 |
Primary Refractory Double Hit Diffuse Large B cell Lymphoma: Response to Salvage Therapy with Ibrutinib and Rituximab
|
Kamble, R.
|
|
2015
|
15 |
S2 |
p. S62-S63
2 p.
|
artikel
|
| 122 |
Progressive Transformation of Germinal Centers: Single Center Experience
|
Özkan, Melda Cömert
|
|
2015
|
15 |
S2 |
p. S39-
1 p.
|
artikel
|
| 123 |
Protein levels of BCL-2, BCL-XL and MCL-1 predict resistance to pro-apoptotic compounds in primary human MDS samples
|
Jilg, Stefanie
|
|
2015
|
15 |
S2 |
p. S42-S43
2 p.
|
artikel
|
| 124 |
Proteomic Profiling Identifies Distinct Bone Marrow Niche Mesenchymal Stem Cell Populations In AML Patients
|
Ruvolo, Peter P.
|
|
2015
|
15 |
S2 |
p. S19-
1 p.
|
artikel
|
| 125 |
Randomized Phase II Study of Clofarabine or Fludarabine Combined with Idarubicin and Cytarabine for the Treatment of Newly Diagnosed AML
|
Yilmaz, Musa
|
|
2015
|
15 |
S2 |
p. S18-
1 p.
|
artikel
|
| 126 |
Risk of Second Primary Malignancies (SPM) in Patients with Follicular Lymphoma (FL)
|
Giri, Smith
|
|
2015
|
15 |
S2 |
p. S72-S73
2 p.
|
artikel
|
| 127 |
Role of Prostate apoptosis response-4 tumor suppressor in the survival and growth of Chronic Lymphocytic Leukemia
|
Nooti, S.K.
|
|
2015
|
15 |
S2 |
p. S28-
1 p.
|
artikel
|
| 128 |
Ruxolitinib (RUX) in combination with 5-Azacytidine (AZA) as therapy for patients with myelofibrosis (MF)
|
Daver, Naval
|
|
2015
|
15 |
S2 |
p. S59-
1 p.
|
artikel
|
| 129 |
Secondary acute myeloid leukemia (sAML) among patients with myeloproliferative neoplasm (MPN)
|
Bhatt, Vijaya Raj
|
|
2015
|
15 |
S2 |
p. S20-S21
2 p.
|
artikel
|
| 130 |
Secondary Hemophagocytic Lymphohistiocytoisis (HLH) in Adults Patients
|
Tamamyan, Gevorg
|
|
2015
|
15 |
S2 |
p. S76-
1 p.
|
artikel
|
| 131 |
Signal transducer and activator of transcription (STAT)-3 is a double edged sword in CLL cells
|
Rozovski, Uri
|
|
2015
|
15 |
S2 |
p. S24-S25
2 p.
|
artikel
|
| 132 |
Single cell genetic analysis of Trisomy12-NOTCH1 mutated chronic lymphocytic leukaemia: Hidden sub-clones
|
Rose-Zerilli, Matthew
|
|
2015
|
15 |
S2 |
p. S23-S24
2 p.
|
artikel
|
| 133 |
Stromal-Derived Factors Modulate Ex Vivo Drug Responses of Primary Acute Myeloid Leukemia Cells
|
Karjalainen, Riikka
|
|
2015
|
15 |
S2 |
p. S8-S9
2 p.
|
artikel
|
| 134 |
Successful non surgical eradication of invasive gastric mucormycosis
|
El Hachem, Georges
|
|
2015
|
15 |
S2 |
p. S52-
1 p.
|
artikel
|
| 135 |
Survival trends in Adult Acute Lymphoblastic Leukemia Patients at Los Angeles County Hospital and Keck Hospital
|
Vahdani, Golnaz
|
|
2015
|
15 |
S2 |
p. S2-S3
2 p.
|
artikel
|
| 136 |
Synergistic induction of apoptotic cell death in AML by targeting Bcl-2 with ABT-199 in combination with Bcl-Xl/ Mcl-1 inhibition or selective kinase inhibitors
|
Zhang, Qi
|
|
2015
|
15 |
S2 |
p. S16-
1 p.
|
artikel
|
| 137 |
Table of Contents
|
|
|
2015
|
15 |
S2 |
p. A3-
1 p.
|
artikel
|
| 138 |
Targeting Galectin As A Strategy To Improve BH3 Mimetic Efficacy For The Therapy Of Acute Myeloid Leukemia
|
Ruvolo, Peter P.
|
|
2015
|
15 |
S2 |
p. S79-
1 p.
|
artikel
|
| 139 |
Targeting of JAK-STAT signaling pathway and BCL-2 family proteins in Ph-like acute lymphoblastic leukemia
|
Tamamyan, Gevorg
|
|
2015
|
15 |
S2 |
p. S4-
1 p.
|
artikel
|
| 140 |
The clinical significance of cereblon expression, as an effective therapeutic target, in patients with diffuse large B-cell lymphoma
|
Xu-Monette, Zijun Y.
|
|
2015
|
15 |
S2 |
p. S74-
1 p.
|
artikel
|
| 141 |
The Effect of Radiotherapy on the Risk of Developing Secondary Solid Tumors in Hodgkin’s Lymphoma Survivors
|
Abou-Antoun, T.
|
|
2015
|
15 |
S2 |
p. S40-
1 p.
|
artikel
|
| 142 |
The Efficacy and Tolerability of Generic of Imatinib in a Very Specific Group of Chronic Myeloid Leukemia
|
Conchon, Monika
|
|
2015
|
15 |
S2 |
p. S36-
1 p.
|
artikel
|
| 143 |
The evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34 + peripheral hematopoietic stem cell mobilisation for allogeneic hematopoieitic stem cell transplant donors
|
Sivgin, Serdar
|
|
2015
|
15 |
S2 |
p. S15-
1 p.
|
artikel
|
| 144 |
The experience of diagnostic and treating splenic diffuse red pulp lymphoma
|
Julhakyan, Hunan L.
|
|
2015
|
15 |
S2 |
p. S69-S70
2 p.
|
artikel
|
| 145 |
The first analysis of quality of life of patients with acute leukemia in Republic of Armenia
|
Hakobyan, Yervand K.
|
|
2015
|
15 |
S2 |
p. S75-
1 p.
|
artikel
|
| 146 |
The Global Burden of Non-Hodgkin Lymphoma
|
Fitzmaurice, Christina
|
|
2015
|
15 |
S2 |
p. S70-
1 p.
|
artikel
|
| 147 |
The Impact of Different TP53 Mutations on Outcome in Patients with Myelodysplastic Syndromes (MDS)
|
Nazha, Aziz
|
|
2015
|
15 |
S2 |
p. S45-
1 p.
|
artikel
|
| 148 |
The incidence and short-term outcomes of acute myeloid leukemia in adults in Armenia: a single-institution study
|
Poghosyan, Kristine
|
|
2015
|
15 |
S2 |
p. S20-
1 p.
|
artikel
|
| 149 |
The Incidence of Thrombosis of Masked PV Compared with PV and ET in A Single Institute
|
Ando, Yayoi
|
|
2015
|
15 |
S2 |
p. S55-
1 p.
|
artikel
|
| 150 |
The MCL-1 targeting effect of alvocidib potentiates the activity of cytarabine and mitoxantrone in a time-sequential regimen in AML
|
Kim, Wontak
|
|
2015
|
15 |
S2 |
p. S18-
1 p.
|
artikel
|
| 151 |
The prognostic importance of immunohistochemical biomarkers in Diffuse Large B Cell Lymphoma
|
Korkmaz, Serdal
|
|
2015
|
15 |
S2 |
p. S60-S61
2 p.
|
artikel
|
| 152 |
The prognostic significance of elevated serum ferritin levels prior to transplantation in patients with lymphoma that underwent autologous hematopoietic stem cell transplantation (autoHSCT): Role of iron overload
|
Sivgin, Serdar
|
|
2015
|
15 |
S2 |
p. S71-
1 p.
|
artikel
|
| 153 |
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia
|
Carrà, Giovanna
|
|
2015
|
15 |
S2 |
p. S25-
1 p.
|
artikel
|
| 154 |
The variable regulatory B10 capacity of Chronic Lymphocytic Leukemias associates with B-cell receptor anergy and epigenetic programming
|
Drennan, Samantha
|
|
2015
|
15 |
S2 |
p. S28-S29
2 p.
|
artikel
|
| 155 |
TP53 and MDM2 single nucleotide polymorphisms influence survival in myelodysplastic syndromes
|
Cluzeau, Thomas
|
|
2015
|
15 |
S2 |
p. S42-
1 p.
|
artikel
|
| 156 |
Treating adults with Hodgkin Lymphoma in Armenia: a report from resource-limited setting
|
Avagyan, Armen
|
|
2015
|
15 |
S2 |
p. S38-
1 p.
|
artikel
|
| 157 |
Updated definition of cure in adult patients with non-APL acute myeloid leukemia
|
Tamamyan, Gevorg
|
|
2015
|
15 |
S2 |
p. S21-
1 p.
|
artikel
|
Tijdschrift beschrijving